Texture and Colour Enhancement Imaging in Improving Detection and Miss Rate of Premalignant Lesions
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-85
SponsorChanghai Hospital
About this trial
Texture and Color Enhancement Imaging (TXI) is a newly developed image-enhancing endoscopy technology that has show potential in improving detection of colorectal lesions. This multicenter, randomized, tandem trial is aimed at evaluating whether TXI is superior to WLI endoscopy in terms of diagnosis of premalignant lesions.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- TXI (Group A)
- TXI followed by WLI (Group B)
- WLI (Group C)
- WLI followed by TXI (Group D)
Treatment groups
2,964 Participants
are divided into 4 treatment groupsLocations
Sponsors and collaborators
Changhai Hospital
Lead sponsor
The First Affiliated Hospital of Dalian Medical University
Collaborator
The Second Hospital of Hebei Medical University
Collaborator
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Collaborator
Huadong Hospital
Collaborator
Shanghai 6th People's Hospital
Collaborator
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborator
The General Hospital of Eastern Theater Command
Collaborator
Jiangsu Provincial People's Hospital
Collaborator
First People's Hospital of Hangzhou
Collaborator
Wenzhou Central Hospital
Collaborator
The First Affiliated Hospital of Nanchang University
Collaborator
Shanxi Coal Center Hospital
Collaborator
Dalian Municipal Central Hospital
Collaborator
Seventh Medical Center of PLA Army General Hospital
Collaborator
Henan Provincial People's Hospital
Collaborator
Zunyi Medical College
Collaborator
Shandong Second People's Hospital
Collaborator
The Third People's Hospital of Chengdu
Collaborator
Lanzhou University Second Hospital
Collaborator
The Third People's Hospital of Jingdezhen
Collaborator
Fudan University Attached Tumor Hospital
Collaborator
Qingyuan People's Hospital
Collaborator
Source ClinicalTrials.gov